244 related articles for article (PubMed ID: 33096365)
1. A qualitative study of repeat naloxone administrations during opioid overdose intervention by people who use opioids in New York City.
Parkin S; Neale J; Brown C; Jones JD; Brandt L; Castillo F; Campbell ANC; Strang J; Comer SD
Int J Drug Policy; 2021 Jan; 87():102968. PubMed ID: 33096365
[TBL] [Abstract][Full Text] [Related]
2. Costs of opioid overdose education and naloxone distribution in New York City.
Behrends CN; Gutkind S; Winkelstein E; Wright M; Dolatshahi J; Welch A; Paone D; Kunins HV; Schackman BR
Subst Abus; 2022; 43(1):692-698. PubMed ID: 34666633
[No Abstract] [Full Text] [Related]
3. Design details for overdose education and take-home naloxone kits: Codesign with family medicine, emergency department, addictions medicine and community.
Sellen K; Goso N; Halleran L; Mulvale-Fletcher A; Sarmiento F; Ligabue F; Handford C; Klaiman M; Milos G; Wright A; Charles M; Sniderman R; Hunt R; Parsons JA; Leece P; Hopkins S; Shahin R; Jüni P; Morrison L; Campbell DM; Strike C; Orkin A;
Health Expect; 2022 Oct; 25(5):2440-2452. PubMed ID: 35909312
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with withdrawal symptoms and anger among people resuscitated from an opioid overdose by take-home naloxone: Exploratory mixed methods analysis.
Neale J; Kalk NJ; Parkin S; Brown C; Brandt L; Campbell ANC; Castillo F; Jones JD; Strang J; Comer SD
J Subst Abuse Treat; 2020 Oct; 117():108099. PubMed ID: 32811629
[TBL] [Abstract][Full Text] [Related]
5. Is a randomised controlled trial of take home naloxone distributed in emergency settings likely to be feasible and acceptable? Findings from a UK qualitative study exploring perspectives of people who use opioids and emergency services staff.
Sampson FC; Hughes J; Long J; Buykx P; Goodacre SW; Snooks H; Edwards A; Evans B; Jones J; Moore C; Johnston S
BMC Emerg Med; 2024 Apr; 24(1):75. PubMed ID: 38679713
[TBL] [Abstract][Full Text] [Related]
6. How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies.
Neale J; Brown C; Campbell ANC; Jones JD; Metz VE; Strang J; Comer SD
Addiction; 2019 Apr; 114(4):708-718. PubMed ID: 30476356
[TBL] [Abstract][Full Text] [Related]
7. Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review.
Moustaqim-Barrette A; Dhillon D; Ng J; Sundvick K; Ali F; Elton-Marshall T; Leece P; Rittenbach K; Ferguson M; Buxton JA
BMC Public Health; 2021 Mar; 21(1):597. PubMed ID: 33771150
[TBL] [Abstract][Full Text] [Related]
8. Overdose and take-home naloxone in emergency settings: A pilot study examining feasibility of delivering brief interventions addressing overdose prevention with 'take-home naloxone' in emergency departments.
Black E; Monds LA; Chan B; Brett J; Hutton JE; Acheson L; Penm J; Harding S; Strumpman D; Demirkol A; Lintzeris N
Emerg Med Australas; 2022 Aug; 34(4):509-518. PubMed ID: 35021268
[TBL] [Abstract][Full Text] [Related]
9. "I'm not going to lay back and watch somebody die": a qualitative study of how people who use drugs' naloxone experiences are shaped by rural risk environment and overdose education/naloxone distribution intervention.
Kesich Z; Ibragimov U; Komro K; Lane K; Livingston M; Young A; Cooper HLF
Harm Reduct J; 2023 Nov; 20(1):166. PubMed ID: 37946233
[TBL] [Abstract][Full Text] [Related]
10. A medical student-led model for telephone-based opioid overdose education and naloxone distribution during the COVID-19 pandemic.
Hughes TM; Kalicki A; Huxley-Reicher Z; Toribio W; Samuels DL; Weiss JJ; Herscher M; Wang L
Subst Abus; 2022; 43(1):988-992. PubMed ID: 35435812
[No Abstract] [Full Text] [Related]
11. Personal experience and awareness of opioid overdose occurrence among peers and willingness to administer naloxone in South Africa: findings from a three-city pilot survey of homeless people who use drugs.
Wilson M; Brumwell A; Stowe MJ; Shelly S; Scheibe A
Harm Reduct J; 2022 Feb; 19(1):17. PubMed ID: 35148779
[TBL] [Abstract][Full Text] [Related]
12. Decision-making by laypersons equipped with an emergency response smartphone app for opioid overdose.
Ataiants J; Reed MK; Schwartz DG; Roth A; Marcu G; Lankenau SE
Int J Drug Policy; 2021 Sep; 95():103250. PubMed ID: 33887699
[TBL] [Abstract][Full Text] [Related]
13. Naloxone protection, social support, network characteristics, and overdose experiences among a cohort of people who use illicit opioids in New York City.
Bennett AS; Scheidell J; Bowles JM; Khan M; Roth A; Hoff L; Marini C; Elliott L
Harm Reduct J; 2022 Mar; 19(1):20. PubMed ID: 35246165
[TBL] [Abstract][Full Text] [Related]
14. Opioid overdose reversals using naloxone in New York City by people who use opioids: Implications for public health and overdose harm reduction approaches from a qualitative study.
Parkin S; Neale J; Brown C; Campbell ANC; Castillo F; Jones JD; Strang J; Comer SD
Int J Drug Policy; 2020 Apr; 79():102751. PubMed ID: 32304981
[TBL] [Abstract][Full Text] [Related]
15. Patient perspectives on an opioid overdose education and naloxone distribution program in the U.S. Department of Veterans Affairs.
Oliva EM; Nevedal A; Lewis ET; McCaa MD; Cochran MF; Konicki PE; Davis CS; Wilder C
Subst Abus; 2016; 37(1):118-26. PubMed ID: 26675643
[TBL] [Abstract][Full Text] [Related]
16. Assessment of a naloxone distribution plan in a veteran population who experienced an opioid-related overdose event.
Alexander M; Hooker J; Stratton M; Huh M; Houck K
J Am Pharm Assoc (2003); 2024; 64(3):101999. PubMed ID: 38151200
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a personally-tailored opioid overdose prevention education and naloxone distribution intervention to promote harm reduction and treatment readiness in individuals actively using illicit opioids.
Winhusen T; Wilder C; Lyons MS; Theobald J; Kropp F; Lewis D
Drug Alcohol Depend; 2020 Nov; 216():108265. PubMed ID: 32919098
[TBL] [Abstract][Full Text] [Related]
18. Non-fatal opioid overdose, naloxone access, and naloxone training among people who recently used opioids or received opioid agonist treatment in Australia: The ETHOS Engage study.
Conway A; Valerio H; Peacock A; Degenhardt L; Hayllar J; Harrod ME; Henderson C; Read P; Gilliver R; Christmass M; Dunlop A; Montebello M; Whitton G; Reid D; Lam T; Alavi M; Silk D; Marshall AD; Treloar C; Dore GJ; Grebely J;
Int J Drug Policy; 2021 Oct; 96():103421. PubMed ID: 34452808
[TBL] [Abstract][Full Text] [Related]
19. Medical providers' knowledge and concerns about opioid overdose education and take-home naloxone rescue kits within Veterans Affairs health care medical treatment settings.
Winograd RP; Davis CS; Niculete M; Oliva E; Martielli RP
Subst Abus; 2017; 38(2):135-140. PubMed ID: 28486076
[TBL] [Abstract][Full Text] [Related]
20. Patient characteristics associated with being offered take home naloxone in a busy, urban emergency department: a retrospective chart review.
O'Brien DC; Dabbs D; Dong K; Veugelers PJ; Hyshka E
BMC Health Serv Res; 2019 Sep; 19(1):632. PubMed ID: 31488142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
